Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia

Zhang, H; Liu, APY; Devidas, M; Lee, SHR; Cao, XY; Pei, DQ; Borowitz, M; Wood, B; Gastier-Foster, JM; Dai, YF; Raetz, E; Larsen, E; Winick, N; Bowman, WP; Karol, S; Yang, WJ; Martin, PL; Carroll, WL; Pui, CH; Mullighan, CG; Evans, WE; Cheng, C; Hunger, SP; Relling, MV; Loh, ML; Yang, JJ

Yang, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas P1 MS313, Memphis, TN 38105 USA.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021; 113 (4): 408

Abstract

Background: Minimal residual disease (MRD) after induction therapy is one of the strongest prognostic factors in childhood acute lymphoblastic leukemi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索